Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Medical Devices — Retail - Devices. Per the activity note to the FY2024 annual report, the company carries out retail trade in medical and orthopedic goods in specialized stores.
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| 3,171 | 4,144 | +30.7% | |
| Total COGS | 2,123 | 2,973 | +40.1% |
| Gross Profit | 1,048 | 1,171 | +11.7% |
| Gross Margin | 33.1% | 28.2% | |
| 832 | 1,147 | +37.9% | |
| EBITDA | 216 | 23 | -89.2% |
| EBITDA Margin | 6.8% | 0.6% | |
| Total D&A | 23 | 40 | +76.7% |
| EBIT / Operating Income | 193 | 17 | nmf |
| Total Interest Income | 1 | 10 | +707.0% |
| Total Interest Expense | 9 | 2 | -75.0% |
| Total Other Income | 25 | 3 | nmf |
| Profit Before Tax | 161 | 6 | nmf |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 161 | 6 | nmf |
| Net Margin | 5.1% | 0.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →